Latest Acute Renal Failure News
Among intermediate- and poor-risk patients, the risk for death was 37% lower with nivolumab plus ipilimumab than with sunitinib.
Higher risk of inflammatory bowel disease with longer use of dipeptidyl peptidase-4 inhibitor
In a study, intact parathyroid hormone levels fell by nearly 10% over 6 months in hemodialysis patients who received intensive treatment for hyperphosphatemia.
Environmental lead exposure tied to all-cause, cardiovascular disease, ischemic heart disease mortality.
Study documents a drop in the incidence of de novo metastatic PCa from 1980 to 2011 in the United States.
Excess calcium following a meal may be deposited in soft tissue and blood vessels, researchers hypothesize.
But no mortality risk reduction associated with weight loss in individuals with coronary heart disease
Strongest associations found for lung and colorectal cancer
Use of 5-alpha-reductase inhibitors before and after diagnosis of the malignancy is associated with a 15% and 22% decreased risk of bladder cancer mortality, respectively.
New study shows that men are at lower risk of prostate cancer for years after they stop taking the medication.
A previous study showed that using 5-ARIs to treat benign prostate hyperplasia decreased the risk of low-grade PCa.
Sucroferric oxyhydroxide and sevelemer are similarly effective in lower phosphorus levels in dialysis patients, but the former is associated with less toxicity and lower pill burden.
Clopidogrel noninferior for patients older than 65 years after acute coronary syndrome hospitalization.
No evidence for circulating tumor DNA assays in early-stage cancer, residual disease detection
Screening and treating all healthy men older than 65 years with testosterone is discouraged.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)